Fresenius Medical Care Corporation (FMS) — the peer cohort

As of 2026-09-23 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Fresenius Medical Care Corporation ranks 6 of 8 in its cohort on the Closelook composite (51/100) — the cohort is led by DexCom Inc at 65/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
FMS Fresenius Medical Care Corporation 51 43 35 84 info 15.7%
PACS PACS Group, Inc. 53 66 40 53 info 17.1%
ENSG The Ensign Group Inc 47 36 35 43 warn 19.5%
RHC.AU Ramsay Health Care Ltd 44 89 23 52 ok 1%
DXCM DexCom Inc 65 84 80 35 bull 3.3%
ARGX argenx NV ADR 64 74 74 27 ok 11.8%
ONC BeiGene, Ltd. 64 81 64 32 ok 5.2%
MEDP Medpace Holdings Inc 63 84 74 29 ok 9%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-23

Quick answers

Who are Fresenius Medical Care Corporation's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: PACS Group, Inc. (PACS), The Ensign Group Inc (ENSG), Ramsay Health Care Ltd (RHC.AU), DexCom Inc (DXCM), argenx NV ADR (ARGX), BeiGene, Ltd. (ONC), Medpace Holdings Inc (MEDP).

How does FMS score against its peers?

Fresenius Medical Care Corporation's composite reads 51/100, ranking 6 of 8 in its cohort as of 2026-09-23; the cohort's highest composite is DexCom Inc at 65/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.